These entries separate a film question, source evidence, counterweight and a provisional assessment. The assessment is the project’s analysis—not an independent review decision. Each entry has a permanent link and a correction route.
Document observation
A working system now, or a possible future platform?
The question raised
The film raises the distinction between a CEO's present-capability assertion and a statement of future potential. The exact film wording and timing still need checking.
What the evidence supports
Exhibit 3696 page 3 uses present-tense language about running comprehensive tests from a finger-stick. The SEC separately alleges misleading investor materials and demonstrations.
Qualifications and counterweight
A presentation does not by itself prove who received it, the date, oral qualifications, test performance or a particular person's state of mind. Future-potential arguments must be matched to the same communication and recipient.
Provisional assessment
The claim must be tested at the date it was communicated, against the actual device, sample, assay menu and disclosures—not against later technical ambitions.
What would resolve the gap
Obtain each dated deck version, distribution evidence, demonstration protocol and relevant testimony; link the film scene without inventing a quotation.
Page-level inspection, not the full delivery history. Wording is evidence of a representation, not demonstrated capability, authorship, delivery to a particular investor or all accompanying qualifications.
Civil allegations · Paragraphs 1–5 and 48–51; retain full document context
Selected passages; not a complete exhibit audit. Allegations must not be relabelled as judicial findings; each investor's actual information requires separate evidence.
Does one platform mean one method can do every blood test?
The question raised
Platform can sound like a universal sensor. That interpretation needs evidence rather than assumption.
What the evidence supports
An integrated platform can combine preparation, several detection modules and software. Blood-cell counting, immunoassays, chemistry and nucleic-acid tests do not become the same measurement because they share a housing.
Qualifications and counterweight
The 2016 company announcement describes a later proposed system. It does not validate earlier devices or prove clinical performance across the menu.
Provisional assessment
Ask what was integrated, which assays worked, and which sample/workflow was validated. An individual successful measurement cannot validate a whole platform.
What would resolve the gap
Build a dated device-and-assay matrix, including external instruments and every manual/off-device step.
Company announcement · 2016 integrated-system description
Previously linked company account; independent performance audit pending. Company descriptions are representations, not independent validation; do not project later architecture back onto earlier devices.
Peer-reviewed comparative study · Abstract and selected methods; 60 healthy adults, 22 tests
Abstract and selected methods; not raw-data reanalysis. A delivered-service comparison, not a teardown establishing the internal instrument for every result, all assays or all patient groups.
Was the promised proprietary device doing the patient testing?
The question raised
The distinction is not simply whether a laboratory produced a number, but how that number was obtained.
What the evidence supports
The SEC alleged that the proprietary analyzer supported few tests and that most patient testing used third-party commercial analyzers. The DOJ trial account also describes instrument limitations.
Qualifications and counterweight
These source types differ. Do not turn the SEC allegation into an assay-by-assay criminal finding or assume every test used the same instrument.
Provisional assessment
A service result, a proprietary-device result and a validated finger-prick result are different propositions.
What would resolve the gap
Match particular assays and dates to laboratory records and instrument logs before assigning a measurement to a device.
Prosecution account of trial and mixed verdict · Verdict summary and account of trial evidence
Selected verdict and evidence passages inspected. Read the verdict count by count. This is not the complete trial record or a finding that every allegation was proven.
Did the intellectual property prove the invention worked?
The question raised
Patented and proprietary can sound like technical verification when used in a pitch.
What the evidence supports
US8283155B2 supplies a concrete starting specification and set of legal claims for a fluidic-system investigation.
Qualifications and counterweight
No full ownership chain, validity assessment or product-to-claim mapping has been completed here. Patent and clinical-validation questions are different.
Provisional assessment
Read the granted claims and relevant dates, then map them to the product and the capability represented to investors. Do not count a patent as an accuracy study.
What would resolve the gap
Record inventors, priority dates, assignees, claim scope and actual implementation separately.
Granted patent record · Bibliographic record; granted claims 1–10, especially 1 and 9
Selected granted claims and original-assignee/publication fields inspected on 21 November 2026; no validity or legal-title audit. A granted patent is not regulatory clearance or clinical validation; product-to-claim mapping remains unverified. Database ownership labels are not a legal opinion.
Page-level inspection, not the full delivery history. Wording is evidence of a representation, not demonstrated capability, authorship, delivery to a particular investor or all accompanying qualifications.
Does a guilty verdict establish every claim made about Theranos?
The question raised
A film discussion can collapse allegations, investor fraud, patient testing and business failure into a single conclusion.
What the evidence supports
The DOJ records one investor-conspiracy conviction and three investor wire-fraud convictions, alongside acquittals and counts on which the jury did not reach a verdict.
Qualifications and counterweight
Neither conviction on some counts nor acquittal on others decides every scientific, historical or moral proposition. A prosecution summary is not the complete record.
Provisional assessment
State the actual result and the legal/source context; examine the underlying claim rather than treating a verdict as a universal fact-check.
What would resolve the gap
Link relevant verdict forms, instructions and evidence for each specific claim, retaining defence qualifications.
Prosecution account of trial and mixed verdict · Verdict summary and account of trial evidence
Selected verdict and evidence passages inspected. Read the verdict count by count. This is not the complete trial record or a finding that every allegation was proven.
Can Holmes's nodding tell us whether she is truthful?
The question raised
A viewer recalls frequent nodding in the first portion of the film. Its frequency has not been measured here.
What the evidence supports
No verified sequence coding, baseline behaviour or unedited footage has been inspected for this question.
Qualifications and counterweight
Listening, conversational timing, agreement, politeness, direction and editing are possible explanations—not conclusions about this person. A gesture is not a lie detector.
Provisional assessment
If studied, record observable behaviour and editing context; do not infer deceit, diagnosis or motive from it.
What would resolve the gap
Code a defined sequence with scene references and a stated counting method, keeping observation separate from interpretation.
No source yet verifies this observation. Treat it as an open question.